 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Trials at Swedish Medical CenterDecember 30, 2003 Tipranavir Early Access ProgramThere are limited openings in this program. Please contact Healther Algren at (206) 386-2820. Protease Inhibitor StudyYou may be eligible to join a research study of a medication for HIV disease if you have taken HIV medications in the past that no longer work for you and you are currently taking a combination of HIV medications and your viral load is over 1,000 copies. Please contact Janice Price at (206) 386-2523.  This article was provided by Seattle Treatment Education Project. It is a part of the publication STEP Ezine.
|
|
Email
Print-Friendly
Glossary
PDF
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
